Industry Supported

Name: Development of Radiopharmaceuticals: Fundamentals, Landscape, BD Deals, CMC Challenges, Theranostic Development, and IP strategies
Start: 2026-03-30T08:30:00-07:00
End: 2026-03-30T14:00:00-07:00

Events from this host

March 2026
Oncology Preclinical Models and Pharmacology Studies for Translational Research: Fundamentals, Applications and Case Studies

March 17 @ 8:45 am - 5:30 pm

Crowne Plaza Hotel, Foster City 1221 Chess Dr, Foster City, CA, United States

Developing effective cancer therapies remains a major challenge, with low translational success despite advances in molecular oncology. A key barrier is the limited predictive power of traditional preclinical models and the need for robust pharmacological evaluation. This workshop addresses these challenges by exploring preclinical models and pharmacology strategies essential for oncology drug development. With the..
Foundational Tools | BIO Savings Week

March 17 @ 11:00 am - 12:00 pm

A focused look at the foundational tools early-stage life science companies need to launch and scale. Learn how membership benefits support HR, finance, compliance, and leadership decisions during the earliest stages. Featured Partners: ADP HR | Greg Hassan, Director of Franchise & Affiliations ADP Tax Credits | Jose Arellano, Senior Director of Channel Strategy Brex..
Live Webinar – Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium

March 17 @ 1:00 pm - 2:00 pm

Virtual Event

Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical. This webinar introduces..
Core Business Operations Support | BIO Savings Week

March 18 @ 11:00 am - 12:00 pm

Virtual Event

BIO Savings Week connects life science companies with the lab and business solutions available through their BIO or state life science association membership. Across three days, you will hear directly from BIO Business Solutions' preferred providers about programs tailored to different roles—from founders and operations leaders to lab managers and admins. All sessions are open..
Safer Labs Through Filtration: Mitigating Overlooked Sources of Chemical Inhalation Exposure

March 18 @ 12:00 pm - 1:00 pm

Virtual Event

Laboratories often prioritize chemical fume hoods to mitigate chemical inhalation hazards, yet many subtle sources of exposure remain overlooked. Benchtop chemistry, common lab equipment (such as balances, 3D printers, HPLC, ICP-MS), and chemical storage can all contribute to airborne contaminants. Over time, Permissible Exposure Limits (PEL) and Threshold Limit Values (TLV) continue to decrease, underscoring..
Empowering Success in Small Pharma / Biotech: Leveraging People and Process for Optimal Results

March 19 @ 9:00 am - 10:00 am

Virtual Event

Scaling a small or mid‑sized biotech isn’t about having endless resources—it’s about using the ones you do have with precision. In these organizations, people are the engine of innovation. They push research forward, uphold quality, and keep the company aligned with regulatory expectations. Even when work is outsourced, strong internal oversight and clear direction remain..
Lab Solutions & Products | BIO Savings Week

March 19 @ 11:00 am - 12:00 pm

Designed for lab managers and R&D leaders, this session explores the lab solutions and benefits that support research environments—from equipment and lab supply procurement to safety and compliance. Featured Partners: Airgas Healthcare | Dalton Speelman, National Account Manager, Airgas Life Sciences American Laboratory Trading | Carrie Kleinle, Director, Product Marketing & Partner Engagement Clean Harbors..
Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises

March 26 @ 11:00 am - 12:00 pm

Virtual Event

During the past seven months, biopharma companies have had to contend with unprecedented change within the upper echelons of the FDA. Among other challenges, executives at small and medium companies have reported communication issues, misaligned expectations and media leaks while attempting to get their products across the regulatory finish line. Notably, many of these investigational..
Development of Radiopharmaceuticals: Fundamentals, Landscape, BD Deals, CMC Challenges, Theranostic Development, and IP strategies

March 30 @ 8:30 am - 2:00 pm

Virtual Event

This workshop offers a comprehensive deep dive into the rapidly evolving field of radiopharmaceuticals. The agenda spans the full development lifecycle, beginning with a high-level view of the market landscape, deal-making trends, and future directions in oncology and beyond. Expert sessions will tackle critical technical hurdles, including CMC challenges, theranostic development, and manufacturing for first-in-human..

March 2026

Get Involved

Whether you're a startup founder, global company, policymaker, or partner, there's a place for you in our thriving ecosystem.